Bellerophon Therapeutics
BLPH
#9684
Rank
€0.38 M
Marketcap
0,03158 €
Share price
0.00%
Change (1 day)
-91.79%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): -1,17 €

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -1,09 €. In 2022 the company made an earnings per share (EPS) of -1,88 € a decrease over its 2021 EPS that were of -1,70 €.

EPS history for Bellerophon Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,17 €-37.56%
2022-1,88 €10.64%
2021-1,70 €-42.86%
2020-2,97 €12.67%
2019-2,64 €-500%
20180,66 €-103.53%
2017-18,68 €-13.75%
2016-21,66 €-48.13%
2015-41,75 €882.98%
2014-4,25 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
4,62 €-523.14%🇺🇸 USA
-2,71 € 148.23%🇺🇸 USA
2,68 €-345.64%🇺🇸 USA
1,38 €-226.45%🇺🇸 USA